Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Boersma

Showing results (21-30 of 757) with videos related to

Pageof 76
Sort By:
Pharmacogenomics|August 18, 2010
Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefitJasper J Brugts, Eric Boersma, Maarten L Simoons
Journal of Magnetic Resonance Imaging : JMRI|February 27, 2009
Normal biventricular function, volumes, and mass in children aged 8 to 17 yearsDaniëlle Robbers-Visser, Eric Boersma, Willem A Helbing
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Drug-eluting stent implantation in acute myocardial infarction. Do we need another randomised trial? (TYPHOON, PASSION and HORIZONS trials)Shuzou Tanimoto, Keiichi Tsuchida, Joost Daemen, et al.
JAMA Internal Medicine|May 7, 2014
Intensive glucose control for acute myocardial infarction--replyMaarten de Mulder, Victor A Umans, Eric Boersma
World Neurosurgery|May 4, 2022
Tenets of Good Practice in Regression Analysis. A Brief TutorialDana Pisică, Ruben Dammers, Eric Boersma, et al.
Pulmonary Pharmacology & Therapeutics|October 28, 2008
Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trialLennert Slobbe, Eric Boersma, Bart J A Rijnders
Statistics in Medicine|May 16, 2025
Risk-Profile Based Monitoring Intervals for Multivariate Longitudinal Biomarker Measurements and Competing Events With Applications in Stable Heart FailureTeun B Petersen, Eric Boersma, Isabella Kardys, et al.
European Journal of Preventive Cardiology|June 5, 2026
Methodological and clinical considerations regarding lipoprotein(a) risk assessment in secondary prevention-authors' replyJose V F de Mira, Isabella Kardys, Eric Boersma
European Journal of Preventive Cardiology|July 8, 2026
Lipoprotein (a) in Patients With Diabetes and High Atherosclerotic Cardiovascular Risk: Risk Enhancer or Risk Modifier? - Authors replyJose V F de Mira, Isabella Kardys, Eric Boersma
Cardiology|February 23, 2022
Development and Internal Validation of a Practical Model to Identify Observe Patients of the European Society of Cardiology 0/1-h Algorithm at Low Risk of a Coronary DiagnosisMurat Arslan, Eric Boersma, Admir Dedic, et al.
Pageof 76

Showing results (21-30 of 757) with videos related to

Sort By:
Pageof 76
Pharmacogenomics|August 18, 2010
Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefitJasper J Brugts, Eric Boersma, Maarten L Simoons
Journal of Magnetic Resonance Imaging : JMRI|February 27, 2009
Normal biventricular function, volumes, and mass in children aged 8 to 17 yearsDaniëlle Robbers-Visser, Eric Boersma, Willem A Helbing
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Drug-eluting stent implantation in acute myocardial infarction. Do we need another randomised trial? (TYPHOON, PASSION and HORIZONS trials)Shuzou Tanimoto, Keiichi Tsuchida, Joost Daemen, et al.
JAMA Internal Medicine|May 7, 2014
Intensive glucose control for acute myocardial infarction--replyMaarten de Mulder, Victor A Umans, Eric Boersma
World Neurosurgery|May 4, 2022
Tenets of Good Practice in Regression Analysis. A Brief TutorialDana Pisică, Ruben Dammers, Eric Boersma, et al.
Pulmonary Pharmacology & Therapeutics|October 28, 2008
Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trialLennert Slobbe, Eric Boersma, Bart J A Rijnders
Statistics in Medicine|May 16, 2025
Risk-Profile Based Monitoring Intervals for Multivariate Longitudinal Biomarker Measurements and Competing Events With Applications in Stable Heart FailureTeun B Petersen, Eric Boersma, Isabella Kardys, et al.
European Journal of Preventive Cardiology|June 5, 2026
Methodological and clinical considerations regarding lipoprotein(a) risk assessment in secondary prevention-authors' replyJose V F de Mira, Isabella Kardys, Eric Boersma
European Journal of Preventive Cardiology|July 8, 2026
Lipoprotein (a) in Patients With Diabetes and High Atherosclerotic Cardiovascular Risk: Risk Enhancer or Risk Modifier? - Authors replyJose V F de Mira, Isabella Kardys, Eric Boersma
Cardiology|February 23, 2022
Development and Internal Validation of a Practical Model to Identify Observe Patients of the European Society of Cardiology 0/1-h Algorithm at Low Risk of a Coronary DiagnosisMurat Arslan, Eric Boersma, Admir Dedic, et al.
Pageof 76